Fresenius SE & Co. (OTCMKTS:FSNUY) Shares Gap Up – Here’s Why

Posted by Brian Himes on Sep 8th, 2026

Fresenius SE & Co. (OTCMKTS:FSNUY – Get Free Report) gapped up before the market opened on Tuesday . The stock had previously closed at $12.72, but opened at $13.53. Fresenius SE & Co. shares last traded at $13.11, with a volume of 3,363 shares traded.

Wall Street Analyst Weigh In

FSNUY has been the subject of a number of recent analyst reports. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating on shares of Fresenius SE & Co. in a research note on Thursday, August 6th. Morgan Stanley reaffirmed an “overweight” rating on shares of Fresenius SE & Co. in a report on Tuesday, July 21st. Three research analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the company currently has an average rating of “Buy”.

Check Out Our Latest Report on FSNUY

Fresenius SE & Co. Price Performance

The firm has a market capitalization of $29.37 billion, a price-to-earnings ratio of 16.50 and a beta of 0.62. The company’s 50 day moving average is $12.84 and its 200 day moving average is $12.58. The company has a quick ratio of 0.98, a current ratio of 1.27 and a debt-to-equity ratio of 0.41.

Fresenius SE & Co. (OTCMKTS:FSNUY – Get Free Report) last issued its quarterly earnings data on Wednesday, August 5th. The company reported $0.24 earnings per share for the quarter, missing the consensus estimate of $0.25 by ($0.01). The business had revenue of $6.91 billion during the quarter, compared to analyst estimates of $6.65 billion. Fresenius SE & Co. had a return on equity of 10.33% and a net margin of 6.67%. On average, equities research analysts anticipate that Fresenius SE & Co. will post 1.08 earnings per share for the current fiscal year.

Fresenius SE & Co. Company Profile

(Get Free Report)

Fresenius SE & Co KGaA is a global healthcare group headquartered in Bad Homburg vor der Höhe, Germany. Founded in 1912 by Eduard Fresenius, the company has grown into one of the world’s leading providers of products and services for dialysis, hospitals and outpatient medical care. Trading on major European exchanges and available over the counter in the U.S. as FSNUY, Fresenius SE & Co brings together a portfolio of specialized healthcare businesses under one corporate umbrella.

The company operates through four main business segments.